{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T17:21:14Z","timestamp":1773336074394,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019594","name":"Yanbian University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019594","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118275","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:59:15Z","timestamp":1761076755000},"page":"118275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Synthesis of amide-linked panaxadiol-indolinedione derivatives: A novel NSD2\/H3K36me2 epigenetic modulator with significant antitumor efficacy"],"prefix":"10.1016","volume":"302","author":[{"given":"Liyan","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonghui","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118275_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.molcel.2011.08.042","article-title":"NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming","volume":"44","author":"Kuo","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2025.118275_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrm3274","article-title":"Understanding the language of Lys36 methylation at histone H3","volume":"13","author":"Wagner","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2025.118275_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbcan.2011.05.004","article-title":"Cancers and the NSD family of histone lysine methyltransferases","volume":"1816","author":"Morishita","year":"2011","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.ejmech.2025.118275_bib4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/hmg\/7.7.1071","article-title":"WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(1;14) multiple myeloma","volume":"7","author":"Stec","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmech.2025.118275_bib5","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026708","article-title":"The role of nuclear receptor\u2013binding SET domain family histone lysine methyltransferases in cancer","volume":"7","author":"Bennett","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ejmech.2025.118275_bib6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/epi.15.32","article-title":"The NSD family of protein methyltransferases in human cancer","volume":"7","author":"Vougiouklakis","year":"2015","journal-title":"Epigenomics"},{"key":"10.1016\/j.ejmech.2025.118275_bib7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbrc.2008.12.093","article-title":"MMSET is overexpressed in cancers: link with tumor aggressiveness","volume":"379","author":"Kassambara","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2025.118275_bib8","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-10-1302","article-title":"The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors","volume":"17","author":"Hudlebusch","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118275_bib9","doi-asserted-by":"crossref","first-page":"14913","DOI":"10.1021\/acs.jmedchem.1c01116","article-title":"Targeting the nuclear receptor-binding SET domain family of Histone lysine methyltransferases for cancer therapy: recent progress and perspectives","volume":"64","author":"Shrestha","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib10","doi-asserted-by":"crossref","unstructured":"E. Martinez-Garcia, R. Popovic, D.-J. Min, S.M.M. Sweet, P.M. Thomas, L. Zamdborg, A. Heffner, C. Will, L. Lamy, L.M. Staudt, D.L. Levens, N.L. Kelleher, J.D. Licht, The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells, (n.d.). https:\/\/doi.org\/10.1182\/blood-2010-07-298349.","DOI":"10.1182\/blood-2010-07-298349"},{"key":"10.1016\/j.ejmech.2025.118275_bib11","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/ng.2777","article-title":"Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia","volume":"45","author":"Jaffe","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmech.2025.118275_bib12","first-page":"25","article-title":"In vitro histone lysine methylation by NSD1, NSD2\/MMSET\/WHSC1 and NSD3\/WHSC1L","volume":"14","author":"Morishita","year":"2014","journal-title":"BMC Struct. Biol."},{"key":"10.1016\/j.ejmech.2025.118275_bib13","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/leu.2012.269","article-title":"MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC","volume":"27","author":"Min","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2025.118275_bib14","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04321-2","article-title":"The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors","volume":"79","author":"Topchu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2025.118275_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231911075","article-title":"NSD2 as a promising target in hematological disorders","volume":"23","author":"Azagra","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2025.118275_bib16","doi-asserted-by":"crossref","first-page":"6837","DOI":"10.2147\/OTT.S259873","article-title":"<p>The role of methyltransferase NSD2 as a potential oncogene in human solid Tumors<\/p>","volume":"13","author":"Chen","year":"2020","journal-title":"OTT"},{"key":"10.1016\/j.ejmech.2025.118275_bib17","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1038\/onc.2012.297","article-title":"The histone methyltransferase MMSET\/WHSC1 activates TWIST1 to promote an epithelial\u2013mesenchymal transition and invasive properties of prostate cancer","volume":"32","author":"Ezponda","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2025.118275_bib18","doi-asserted-by":"crossref","first-page":"13750","DOI":"10.1074\/jbc.RA118.004274","article-title":"High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2","volume":"293","author":"Coussens","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113592","article-title":"5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma","volume":"222","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib20","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/acs.jmedchem.0c01768","article-title":"Discovery of small-molecule antagonists of the PWWP domain of NSD2","volume":"64","author":"Ferreira de Freitas","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41589-021-00898-0","article-title":"A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization","volume":"18","author":"Dilworth","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118275_bib22","doi-asserted-by":"crossref","first-page":"7033","DOI":"10.2147\/OTT.S248570","article-title":"WHSC1 promotes cell proliferation, migration, and invasion in hepatocellular carcinoma by activating mTORC1 signaling","volume":"13","author":"Dai","year":"2020","journal-title":"OTT"},{"key":"10.1016\/j.ejmech.2025.118275_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104078","article-title":"Novel panaxadiol triazole derivatives induce apoptosis in HepG-2 cells through the mitochondrial pathway","volume":"102","author":"Xiao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105392","article-title":"Panaxadiol as a major metabolite of AD-1 can significantly inhibit the proliferation and migration of breast cancer cells: in vitro and in vivo study","volume":"116","author":"Xu","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib25","doi-asserted-by":"crossref","first-page":"22830","DOI":"10.18632\/aging.203575","article-title":"Inhibition of JAK2\/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer","volume":"13","author":"Fan","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.ejmech.2025.118275_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/157340607779317508","article-title":"Isolation, structural determination, and evaluation of the biological activity of 20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol [20(S)-25-OCH3-PPD], a novel natural product from Panax notoginseng","volume":"3","author":"Zhao","year":"2007","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib27","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1016\/j.bmcl.2017.06.061","article-title":"Synthesis and anti-tumor evaluation of panaxadiol halogen-derivatives","volume":"27","author":"Xiao","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.118275_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129045","article-title":"Novel ginsenoside derivatives induce apoptosis in HepG-2 cells via the MDM2-p53 signaling pathway","volume":"78","author":"Teng","year":"2022","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.118275_bib29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cclet.2014.11.013","article-title":"Efficient synthesis of panaxadiol derivatives using continuous-flow microreactor and evaluation of anti-tumor activity","volume":"26","author":"Wu","year":"2015","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118275_bib30","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.ejmech.2011.02.022","article-title":"Synthesis and anti-tumor evaluation of panaxadiol derivatives","volume":"46","author":"Liu","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104150","article-title":"Rational design, synthesis and biological evaluation of triphenylphosphonium-ginsenoside conjugates as mitochondria-targeting anti-cancer agents","volume":"103","author":"Ma","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.118005","article-title":"A novel 20 (R) dammarane panaxadiol-indole-2 \u2032,3\u2019 -dione derivative was found to inhibit the growth and migration of colorectal cancer cells by inhibiting EGFR-mediated RalA\/EMT pathway","volume":"298","author":"Tan","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111768","article-title":"3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: synthesis, in vitro biological evaluation and in silico insights","volume":"184","author":"Abo-Ashour","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib34","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1016\/j.bmc.2012.05.079","article-title":"Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein","volume":"20","author":"Li","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib35","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2289355","article-title":"Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations","volume":"39","author":"Jin","year":"2024","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib36","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1074\/jbc.M116.720748","article-title":"A PWWP domain of Histone-Lysine N-Methyltransferase NSD2 binds to dimethylated Lys-36 of histone H3 and regulates NSD2 function at chromatin","volume":"291","author":"Sankaran","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118275_bib37","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.7150\/ijms.36128","article-title":"Knockdown of NSD2 suppresses renal cell carcinoma metastasis by inhibiting epithelial-mesenchymal transition","volume":"16","author":"Han","year":"2019","journal-title":"Int. J. Med. Sci."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425010402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:01:26Z","timestamp":1773295286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425010402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"alternative-id":["S0223523425010402"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118275","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of amide-linked panaxadiol-indolinedione derivatives: A novel NSD2\/H3K36me2 epigenetic modulator with significant antitumor efficacy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118275"}}